Our microwave tech lands in the Middle East

In a milestone moment, we are delighted to be launching the Swift® device in the UAE thanks to our successful partnership with Neomed Trading.

Neomed will be launching, promoting and servicing Swift® to dermatologists, aesthetic doctors and podiatrists across the Middle East and North African regions, with more launches expected in the next six months.

Our EMEA VP of Sales, Stella Zervos said: "Our strategic partnership with Neomed Trading marks an essential milestone in Emblation’s expansion plans for the Middle East.

"Its expertise and focused approach augment Swift®’s value proposition to our clinics and dermatologists in the region."

Swift® is currently available in clinics across the UK, US, Canada, Australia, and New Zealand and has been used in almost 200,000 treatments since it was launched in 2016.

Elie Helou, Swift® partner for the Middle East said: "I am thrilled to be working in partnership with Emblation to introduce Swift® in the Middle East. I believe that the introduction of this award-winning technology will complement the high standards of medical care already available in the region.

"Swift® will give healthcare practitioners the confidence to provide successful treatment for skin lesions and allow them to widen their treatment offering."

Our device is currently available in clinics across the UK, US, Canada, Australia, and New Zealand and has been used in almost 200,000 treatments since we launched it in 2016.